Top Cannabis Stocks

[Pennybuster]

$AMRS Filing With Bill and Melinda Gates Foundation.


http://ih.advfn.com/p.php?pid=nmona&article=71476165

As previously reported, on April 8, 2016, Amyris, Inc. (the “ Company ”) and the Bill & Melinda Gates Foundation (the “ Gates Foundation ”) entered into (i) a Securities Purchase Agreement (the “ Purchase Agreement ”), pursuant to which the Company agreed to sell and issue 4,385,964 shares of its common stock (the “ Shares ”) to the Gates Foundation at a purchase price per share equal to $1.14 (the “ Gates Foundation Investment ”) and (ii) a Charitable Purposes Letter Agreement (the “ Letter Agreement ”), pursuant to which the Company agreed to use the proceeds from the Gates Foundation Investment to develop a yeast strain that produces artemisinic acid and/or amorphadiene at a low cost and to supply such artemisinic acid and amorphadiene to companies qualified to convert artemisinic acid and amorphadiene to artemisinin for inclusion in artemisinin combination therapies used to treat malaria. The entry into the Purchase Agreement and the Letter Agreement was previously reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 11, 2016, which is incorporated herein by reference.

On May 10, 2016, the Company and the Gates Foundation closed the Gates Foundation Investment, resulting in the issuance of 4,385,964 Shares to the Gates Foundation for proceeds to the Company of approximately $5.0 million.